Afinum 9 acquires a majority stake in mymediset, a world-leading technology provider for SAP-integrated medical device management in the healthcare industry, partnering up with founder and CEO Michael Knauer to drive and execute the business’s next growth phase. This acquisition marks the sixth platform investment by the Afinum 9 fund since the beginning of its investment period in October 2021.
Mymediset provides fully SAP-integrated software and cloud-based Apps for more efficient, responsible, and reliable medical device management. The company currently operates international subsidiaries in Boston (US) and Singapore and is in the process of opening two new offices in Cape Town (South Africa) and São Paulo (Brazil). The success of mymediset’s software offering is based on long-term experience in the industry, but even more the company’s deep technological and service capabilities. Among its growing customer base are the large global medical OEMs.
Over recent years, the company has grown strongly and expanded internationally to best serve its customer base in now over 40 countries. In this context, the previous sole shareholder, Michael Knauer, has searched for a growth partner with a proven track-record and experience in the software and MedTech space to optimally support the next development phase of the company.
The business is headquartered in Freiburg (Germany) and currently employs a workforce of c. 40 people across five continents. Michael Knauer remains CEO and significantly invested in the company.